A study published in a recent issue of the journal Lupus characterizes a new potential biomarker of fatigue in people with lupus.
The development of a single test that can simultaneously measure several different autoantibodies important in lupus could be important and useful.
The results of this study highlight the important role of lupus anticoagulant, as well as that of a previous blood clot, in adverse pregnancy outcomes.
The results of this study reveal differences in autoantibody profiles over time in people with lupus, with important ethnicity-related differences, and their relationship to lupus-mediated organ damage over time.
The researchers hoped to learn about the degree to which sex-specific genetic differences contribute to the susceptibility to developing lupus.
This study examined the relationship between levels of vitamin D and autoantibodies in people with lupus.
The researchers hoped to learn about the relationship between the presence of specific lupus susceptibility genes and the development of specific disease manifestations.
For years, researchers have investigated the possibility of inhibiting the actions of lupus-related autoantibodies to reduce the extent of organ damage. Further research in this area has the potential to facilitate the development of new therapies for people with lupus.